Wearable Insoles for Recurrent Diabetic Ulcer Prevention
NCT: NCT07674420 · ACTIVE_NOT_RECRUITING
Brief Summary
The primary objective of the study is to demonstrate the clinical advantages of using the Orpyx SI Sensory Insole (SI) system as an adjunct to standard of care in reducing plantar ulceration in high-risk individuals. The investigators aim to understand participant quality of life, the economic impact and cost-effectiveness of the Orpyx SI insole system, and to evaluate participant engagement and compliance.
Frequently Asked Questions
What is Wearable Insoles for Recurrent Diabetic Ulcer Prevention?
Wearable Insoles for Recurrent Diabetic Ulcer Prevention is a clinical trial registered under NCT07674420. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07674420?
The current status of NCT07674420 (Wearable Insoles for Recurrent Diabetic Ulcer Prevention) is: ACTIVE_NOT_RECRUITING.
When did Wearable Insoles for Recurrent Diabetic Ulcer Prevention start?
Wearable Insoles for Recurrent Diabetic Ulcer Prevention started on 2023-10-17.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.